Dexmedetomidine administration is associated with reduced mortality in patients with sepsis-induced acute respiratory distress syndrome: a retrospective study
Abstract Background Although studies have revealed the benefits of using dexmedetomidine (DEX) in treating rodent models of acute lung injury (ALI) by improving their survival rates, clinical investigation on the effect of DEX on patients with acute respiratory distress syndrome (ARDS) remains scarc...
Saved in:
| Main Authors: | Jianguo Zhang, Zhaoyuan Jia, Yu Zhang, Zhimin Tao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | BMC Anesthesiology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12871-025-02961-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dexmedetomidine administration reduced mortality in patients with acute respiratory distress syndrome: a propensity score-matched cohort analysis
by: Conglin Ye, et al.
Published: (2025-04-01) -
Effect of Neutrophil Elastase Inhibitor (Sivelestat Sodium) on Oxygenation in Patients with Sepsis-Induced Acute Respiratory Distress Syndrome
by: Wu T, et al.
Published: (2025-03-01) -
Associations between urinary glycosaminoglycans and onset of acute respiratory distress syndrome in sepsis patients: a prospective exploratory study
by: Ziyuan Shen, et al.
Published: (2025-05-01) -
Acute respiratory distress syndrome due to sepsis caused by Bacteroides ovatus after acute appendicectomy
by: Yoshinobu Fuse, et al.
Published: (2022-06-01) -
Clinical management of sepsis-associated acute respiratory distress syndrome: current evidence and future directions
by: Liang Liu, et al.
Published: (2025-05-01)